• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Agios Pharmaceuticals Inc

+ Add to Watchlist

8AP:GR

89.451 EUR 3.315 3.85%

As of 12:42:40 ET on 12/17/2014.

Snapshot for Agios Pharmaceuticals Inc (8AP)

Open: 85.145 Day's Range: 84.541 - 90.936 Volume: 303
Previous Close: 86.136 52wk Range: 15.595 - 99.367 1-Yr Rtn: +450.91%

Stock Chart for 8AP

No chart data available.
  • 8AP:GR 89.451
  • 1D
  • 1M
  • 1Y
86.136
Interactive 8AP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8AP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.4290
Est. PEG Ratio -
Market Cap (M EUR) 3,276.50
Shares Outstanding (M) 36.63
30 Day Average Volume 291
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8AP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 8AP

Agios Pharmaceuticals, Inc. discovers and develops therapeutics in the field of cancer metabolism. The Company develops drugs focusing on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals operates in the United States.

David P SchenkeinChief Executive OfficerJ Duncan HiggonsChief Operating Officer
Craig MuirCTO/CIOChris BowdenChief Medical Officer
More Company Profile & Key Executives for 8AP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil